LIGAND PHARMACEUTICALS INCORPORATED
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2022
Total Assets: $762.7M
Liabilities Breakdown FY2022
Total Liabilities: $165.2M
Asset Breakdown
Total Assets: $762.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $45.0M | 5.9% |
| Accounts Receivable | $30.4M | 4.0% |
| Inventory | $13.3M | 1.7% |
| Property, Plant & Equipment | $12.5M | 1.6% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $342.5M | 44.9% |
| Other Assets | $319.0M | 41.8% |
Liabilities Breakdown
Total Liabilities: $165.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.3M | 3.2% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $159.9M | 96.8% |